First, although we have performed both in vitro and in vivo functional assays confirming the oncogenic role of RFX1 in tumor progression, the specific immunomodulatory mechanisms–such as its regulation of immune cell recruitment or immune evasion pathways–were not directly addressed and require further mechanistic studies. This evidence concerns the gene RFX1 and neoplasm.